The aim of this study was to determine if a baseline high-sensitivity troponin T (hsTnT) value ≤99th percentile upper reference limit (0.014 μg/l ["low hsTnT"]) identifies patients at low risk for adverse outcomes.

Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial / Pang, P.S., Teerlink, J.R., Voors, A.A., Ponikowski, P., Greenberg, B.H., Filippatos, G., Felker, G.M., Davison, B.A., Cotter, G., Kriger, J., Prescott, M.F., Hua, T.A., Severin, T., Metra, M.. - In: JACC. HEART FAILURE. - ISSN 2213-1787. - 4:7(2016), pp. 591-599. [10.1016/j.jchf.2016.02.009]

Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial

Metra, Marco
2016-01-01

Abstract

The aim of this study was to determine if a baseline high-sensitivity troponin T (hsTnT) value ≤99th percentile upper reference limit (0.014 μg/l ["low hsTnT"]) identifies patients at low risk for adverse outcomes.
2016
acute heart failure
emergency department
risk stratification
serelaxin
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/193509
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 52
  • ???jsp.display-item.citation.isi??? 48
social impact